About Bio-Path
Overview
Leadership
Board of Directors
Scientific Advisory Board
Partnering Opportunities
Technology
Pipeline
Pipeline
Prexigebersen
BP1001-A
BP1002
BP1003
Patients
Investors
Overview
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us
SEC Form 8-K: Regaining Nasdaq Compliance
BPTH_Form_8-K_2024_Nasdaq_Notice_re_Regaining_Compliance
About Bio-Path
Overview
Leadership
Board of Directors
Scientific Advisory Board
Partnering Opportunities
Technology
Pipeline
Pipeline
Prexigebersen
BP1001-A
BP1002
BP1003
Patients
Investors
Overview
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us